期刊
NANO TODAY
卷 5, 期 4, 页码 296-312出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.nantod.2010.06.007
关键词
Drug delivery; Nanoparticles; Liver targeting; Hepatitis B virus infection; Liver fibrosis; Hepatocellular carcinoma (HCC)
资金
- National Basic Research Program 973 of P.R. China [2007CB513003]
- Biomedical Research Council
- Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research, Singapore
- National University of Singapore
Liver diseases, particularly hepatitis B virus infections, liver cirrhosis and hepatocellular carcinoma continue to pose a significant health challenge worldwide due to the dire lack of curative treatment options besides liver resection and transplantation. Nanoparticle therapeutics, comprising of drugs, nucleic acids or proteins in association with a carrier, have emerged as safe and efficient systems in the treatment of the respective liver diseases. This review describes targeting strategies employed in relation to liver anatomy and disease etiologies, summarizes recent advances in the field and discusses the challenges and future perspectives for the effective treatment of liver diseases using polymer- and lipid-based nanoparticle therapeutics. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据